XML 35 R14.htm IDEA: XBRL DOCUMENT

EARNINGS (LOSS) PER SHARE

9 Months Ended

Sep. 30, 2025

EARNINGS (LOSS) PER SHARE

EARNINGS (LOSS) PER SHARE

(8) EARNINGS (LOSS) PER SHARE

Basic earnings (loss) per share are computed by dividing net income (loss) by the weighted-average number of common shares outstanding during the period. Diluted earnings (loss) per share is computed by dividing net (loss) income by the weighted-average

number of common shares outstanding and the number of dilutive potential common share equivalents during the period. Dilution resulting from stock-based compensation plans is determined using the treasury stock method and dilution resulting from the 2023 Convertible Senior Notes is determined using the if-converted method. In periods of losses, diluted loss per share is computed on the same basis as basic loss per share as the inclusion of any other potential common shares outstanding would be anti-dilutive.

The calculation of basic and diluted earnings (loss) per share for the three and nine months ended September 30, 2025 and 2024 are as follows (in thousands, except per share data):


		For the Three Months Ended September 30,						For the Nine Months Ended September 30,
		2025			2024			2025			2024
Basic earnings (loss) per share
Net income (loss)		$	(42,914)		$	2,382		$	(73,343)		$	3,609
Basic weighted average shares outstanding			30,314			31,775			30,721			31,960
Basic earnings (loss) per share		$	(1.42)		$	0.07		$	(2.39)		$	0.11

Diluted earnings (loss) per share
Net income (loss)		$	(42,914)		$	2,382		$	(73,343)		$	3,609
Weighted average shares outstanding			30,314			31,775			30,721			31,960
Effect of dilutive securities - options and restricted stock			—			313			—			380
Diluted weighted-average shares outstanding			30,314			32,088			30,721			32,340
Diluted earnings per share (loss)		$	(1.42)		$	0.07		$	(2.39)		$	0.11

For the three and nine months ended September 30, 2025, diluted loss per share is computed on the same basis as basic loss per share as the inclusion of any other potential common shares outstanding would be anti-dilutive. For the three and nine months ended September 30, 2024, equity grants of 54,000 and 13,000 shares of common stock, respectively, were excluded from the dilutive stock calculation because their effect would have been anti-dilutive.

For both the three and nine months ended September 30, 2025, and 2024 conversion options to purchase 5.6 million shares resulting from the 2023 Convertible Senior Notes, were excluded from the dilutive stock calculation because their effect would have been anti-dilutive (see Note 10 – Convertible Senior Notes).